以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 证券之星消息，12月17日养殖业板块较上一交易日上涨0.39%，晓鸣股份领涨。当日上证指数报收于 3870.28，上涨1.19%。深证成指报收于13224.51，上涨2.4%。养殖业板块个股涨跌见下表： 从资金流向上来看，当日养殖业板块主力资金净流出2.66亿元，游资资金净流入1.75亿元，散户资金净 流入9087.0万元。养殖业板块个股资金流向见下表： ...

从资金流向上来看，当日养殖业板块主力资金净流入1124.65万元，游资资金净流入248.51万元，散户资 金净流出1373.16万元。养殖业板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 000735 | 罗牛山 | 4270.10万 | 1.53% | -2381.34万 | -0.85% | -1888.76万 | -0.68% | | 300498 温氏股份 | | 2160.29万 | 5.09% | -1022.58万 | -2.41% | -1137.71万 | -2.68% | | 300967 晓鸣股份 | | 728.00万 | 7.51% | 107.64万 | 1.11% | -835.64万 | -8.62% | | 605296 神农集团 | | 643.70万 | 9.91% | -132.66万 | -2.04% | -511.04万 | -7.86% | | ...

今日聚焦 1、贵州茅台：2025年中期分红300亿元 股权登记日为12月18日 贵州茅台(600519.SH)公告称，公司2025年中期利润分配方案已获股东大会通过，将以总股本12.52亿股 为基数，每股派发23.957元现金红利（含税），共计派发300.01亿元（含税）。股权登记日为2025年12 月18日，除权（息）日和现金红利发放日均为2025年12月19日。部分股东的红利将由公司自行发放。扣 税说明根据不同股东类型，分别按10%或20%税率代扣代缴所得税。 2、宁德时代：拟注册发行不超过100亿元债券 宁德时代(300750.SZ)12月10日公告，公司拟注册发行不超过100亿元（含100亿元）的债券，本次发行 的债券的期限不超过5年，主要用于项目建设、补充营运资金、偿还有息负债等。 3、3连板永辉超市：公司股票存在市场情绪过热情形及较高的炒作风险 3连板永辉超市(601933.SH)12月10日披露股票交易风险提示公告，经公司自查，截至目前，公司目前生 产经营活动正常，门店调改稳步有序进行中，内外部经营环境未发生重大变化，不存在应披露而未披露 的重大事项。鉴于近期公司股票交易价格涨幅较大，存在市场情 ...

Group 1 - Jicheng Electronics won a total of 15 bids from the State Grid Corporation, with a total bid amount of approximately 215 million yuan, accounting for 8.27% of the company's projected revenue for 2024 [2] - Jianmin Group's chemical generic drug, Ambrutoro Oral Solution, has been approved for market launch by the National Medical Products Administration, aimed at treating cough and wheezing caused by chronic bronchitis and emphysema [3] - Taiji Industry's subsidiary plans to transfer accounts receivable not exceeding 85 million USD to optimize cash flow, with an expected service fee of approximately 285,000 USD [4] Group 2 - Nanjing Pharmaceutical's subsidiary plans to invest 398 million yuan in a modern pharmaceutical logistics expansion project, with a construction period of approximately 35 months [5] - Ruili Kemi received a development notification from a well-known domestic flying car company to supply core components [6] - Ding Tong Technology announced that several executives plan to reduce their holdings by a total of no more than 45,300 shares, representing about 0.032% of the total share capital [7][8] Group 3 - Ninghu Expressway's subsidiary plans to invest no more than 9.033 billion yuan in the construction of the Nanyang Yangtze River Bridge South Connection Project [10] - Wuliangye announced a mid-term profit distribution plan for 2025, proposing a cash dividend of 25.78 yuan per 10 shares, totaling approximately 10 billion yuan [12] - Beixin Road and Bridge's subsidiary won a bid for a project worth 180 million yuan [14] Group 4 - Minhe Livestock reported a 7.75% month-on-month increase in sales revenue from commodity chick sales in November [15] - Xuelong Group plans to invest 100 million yuan to establish a wholly-owned subsidiary for vertical integration in the aluminum and magnesium technology sector [16] - Shengnong Development reported a 15.77% year-on-year increase in sales revenue in November, with significant growth in both poultry and processed meat products [17] Group 5 - Xingyu Co., Ltd. plans to repurchase shares worth 200 million to 300 million yuan for employee stock ownership plans [18] - Quan Chai Power intends to use 50 million yuan of idle funds to purchase structured deposit products [19] - Shibei High-tech appointed Zhao Junhong as the new deputy general manager [20] Group 6 - Fuan Pharmaceutical's subsidiary received a drug registration certificate for injectable isavuconazole, expanding its anti-infection product line [21] - Xiaoming Co. reported a 49.73% year-on-year decline in chicken product sales revenue in November [22] - Baiao Chemical adjusted its share repurchase price ceiling to no more than 48.95 yuan per share [23] Group 7 - Hefei China reported a 26.02% year-on-year decline in consolidated revenue for the first 11 months [24] - Laimei Pharmaceutical's subsidiary received medical device registration certificates for two endoscope products [25][26] - Xiantan Co. reported an 11.63% year-on-year increase in chicken product sales revenue in November [27] Group 8 - Qilin Security received government subsidies totaling 5.4014 million yuan [28] - Blue Sky Gas's controlling shareholder's 30.9134 million shares were judicially frozen, accounting for 4.33% of the total share capital [29] - Tieke Railway signed a contract for high-speed railway fasteners worth 654 million yuan, accounting for 41.08% of the company's projected revenue for 2024 [30] Group 9 - David Medical's electric surgical table received a medical device registration certificate [31] - Zhendong Pharmaceutical's affiliate's core product new drug application was accepted by the CDE [32] - Shanghai Pharmaceutical's apple acid sitagliptin tablet application for market approval was granted by the National Medical Products Administration [33] Group 10 - Nanjiao Food reported a 1.14% year-on-year increase in consolidated revenue for November [34]

智通财经APP讯，晓鸣股份(300967.SZ)披露2025年11月鸡产品销售情况，公司2025年11月销售鸡产品 1904.13万羽，销售收入4666.52万元，环比变动分别为-2.14%、-17.11%，同比变动分别 为-21.05%、-49.73%。 ...

新京报贝壳财经讯 12月10日，晓鸣股份公告，公司2025年11月销售鸡产品1904.13万羽，销售收入 4666.52万元，环比变动分别为-2.14%、-17.11%，同比变动分别为-21.05%、-49.73%。 编辑 王进雨 ...

格隆汇12月10日丨晓鸣股份(300967.SZ)公布，2025年11月销售鸡产品1,904.13万羽，销售收入4,666.52 万元，环比变动分别为-2.14%、-17.11%，同比变动分别为-21.05%、-49.73%。 ...

晓鸣股份（300967）(300967.SZ)披露2025年11月鸡产品销售情况，公司2025年11月销售鸡产品1904.13 万羽，销售收入4666.52万元，环比变动分别为-2.14%、-17.11%，同比变动分别为-21.05%、-49.73%。 ...

人民财讯12月10日电，晓鸣股份（300967）12月10日公告，公司2025年11月销售鸡产品1904.13万羽， 销售收入4666.52万元，环比变动分别为-2.14%、-17.11%，同比变动分别为-21.05%、-49.73%。2025年 11月，公司鸡产品销售数量与销售收入出现一定波动，主要受行业整体供需关系影响。当前全国在产蛋 鸡存栏量仍处高位，鸡蛋消费进入季节性消费淡季，市场需求较为平淡，加之货源供应相对充足，蛋价 低位运行，蛋鸡养殖持续亏损，养殖单位对后市预期趋于谨慎，补栏积极性有所减弱，导致鸡苗销售数 量及价格继续回调。同时，生猪价格走势偏弱，也对鸡蛋消费形成一定的间接抑制。 ...

晓鸣股份公告，公司2025年11月销售鸡产品1904.13万羽，销售收入4666.52万元，环比变动分别 为-2.14%、-17.11%，同比变动分别为-21.05%、-49.73%。 ...